Entrectinib in locally advanced/metastatic ROS1 and NTRK...

Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

de Braud, F., Siena, S., Barlesi, F., Drilon, A., Simmons, B., Huang, X., Osborne, S., Doebele, R.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz420.003
Date:
November, 2019
File:
PDF, 87 KB
english, 2019
Conversion to is in progress
Conversion to is failed